THIS ACQUISITION WILL ALLOW BARDA TO INVEST PROJECT BIOSHIELD FUNDS FOR LATE-STAGE CLINICAL DEVELOPMENT, RE…
Award details are derived from public USAspending.gov records. Not a bid recommendation.
Award details
- Award ID
- 75A50126C00010
- Contractor
- Awarding agency
- Department of Health and Human Services
- Sub-agency / office
- Office of Assistant Secretary for Preparedness and Response
- Award amount
- $96,058,494
- Period of performance
- Sep 30, 2026 – Dec 31, 2034
- NAICS
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
- PSC
- PSC AN11
- Place of performance
- VA
Public award description
THIS ACQUISITION WILL ALLOW BARDA TO INVEST PROJECT BIOSHIELD FUNDS FOR LATE-STAGE CLINICAL DEVELOPMENT, REGULATORY APPROVAL FOR 2-PAM AUTOINJECTORS (AS A DRUG/DEVICE COMBINATION PRODUCT) TO TREAT ORGANOPHOSPHATE (OP) POISONING, INCLUDING NERVE AGENT
Find out who's winning similar federal contracts
Discover comparable awards, related contractors, and agency purchasing history.